Edgewise Therapeutics Inc (EWTX)
US$ 14.890.47%
Price Chart
Key Statistics
Market Cap
$ 1.57B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
860.97K
52W High
$ 38.12
52W Low
$ 10.60
Dividend Yield
0.00%
Beta
0.37
Technicals
50-Day MA
18.5876
200-Day MA
24.6793
52 Week High
38.12
52 Week Low
10.6
About EWTX
Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.
Employees
110
Headquarters
Boulder, CO
CEO
Dr. Kevin Koch Ph.D.
Latest News
Muscle Disease Leader Edgewise Therapeutics Takes Stage at RBC Healthcare Conference - Stock Titan
8 hours ago • Google News
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Acquired by Algert Global LLC - MarketBeat
16 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg